Xeris Biopharma Holdings Stock (NASDAQ: XERS)

Xeris Biopharma Holdings

XERIS BIOPHARMA HOLDINGS INC

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BFLY

LWAY

SKYH

SPNS

XERS

Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Penny stock: gli insider muovono il mercato con acquisti strategici

Long Ideas

Penny Stocks

Insider Trades

BCOV

PGEN

More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying

STKS

Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings Inc

Press Releases

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

Xeris to Participate in Upcoming Investor Conferences

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Xeris Announces Changes to Its Board of Directors

VRNA

Alumis

Arvinas

BGM Group

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Evolus

GH Research

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

Harrow

Indivior

Innoviva

Liquidia

Maze Therapeutics

Nuvation Bio

Ocular Therapeutix

Omeros

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

SIGA Technologies

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Tilray Brands

Trevi Therapeutics

Wave Life Sciences Ltd. - Ordinary Shares

WAVE Life Sciences

Zevra Therapeutics

Leerink Partners

Craig-Hallum

Piper Sandler

HC Wainwright & Co.

Jefferies

Comments

Xeris Biopharma Holdings

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga